Orchestration of Angiogenesis and Arteriovenous Contribution by Angiopoietins and Vascular Endothelial Growth Factor (VEGF)

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2002 Jun 6

PMID 12048246

Citations 89

Authors

Richard P Visconti

Charlene D Richardson

Thomas N Sato

Affiliations

Soon will be listed here.

Abstract

Multiple classes of factors contribute to angiogenesis. In past years, the primary focus has been to understand the functions of individual classes of angiogenic factors. However, few studies have focused on the combinatorial roles of multiple classes of factors in angiogenesis. In this report, we have investigated the in vivo angiogenic processes regulated by two major classes of angiogenic factors, the angiopoietins and vascular endothelial growth factor (VEGF). Here we show that angiopoietin-1, a factor previously considered to be proangiogenic, can offset VEGF-induced angiogenesis in vivo. We also provide direct in vivo evidence for the synergistic effect of angiopoietin-2 and VEGF on the induction of angiogenesis. Furthermore, we show that these two classes of factors control the ratio of arterial and venous blood vessel types during angiogenesis. We believe that our study is a step toward understanding how multiple classes of factors harmonize angiogenesis and blood vessel types.

Citing Articles

Insights to Ang/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases.

Sha L, Zhao Y, Li S, Wei D, Tao Y, Wang Y J Transl Med. 2024; 22(1):898.

PMID: 39367441 PMC: 11451039. DOI: 10.1186/s12967-024-05441-y.

Catalpol Prevents Glomerular Angiogenesis Induced by Advanced Glycation End Products via Inhibiting Galectin-3.

Sun W, Gao Y, Cao Y, Lu J, Lv G, Xu H Curr Med Sci. 2023; 43(4):668-678.

PMID: 37480413 DOI: 10.1007/s11596-023-2750-5.

Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis.

Balaziova E, Vymola P, Hrabal P, Mateu R, Zubal M, Tomas R Cancers (Basel). 2021; 13(13).

PMID: 34282761 PMC: 8267680. DOI: 10.3390/cancers13133304.

Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data.

Joussen A, Ricci F, Paris L, Korn C, Quezada-Ruiz C, Zarbin M Eye (Lond). 2021; 35(5):1305-1316.

PMID: 33564135 PMC: 8182896. DOI: 10.1038/s41433-020-01377-x.

Pregnancy success in mice requires appropriate cannabinoid receptor signaling for primary decidua formation.

Li Y, Dewar A, Kim Y, Dey S, Sun X Elife. 2020; 9.

PMID: 32990600 PMC: 7550189. DOI: 10.7554/eLife.61762.

References

Schlaeger T, Qin Y, Fujiwara Y, Magram J, Sato T . Vascular endothelial cell lineage-specific promoter in transgenic mice. Development. 1995; 121(4):1089-98. DOI: 10.1242/dev.121.4.1089. View

Thurston G, Suri C, Smith K, McClain J, Sato T, Yancopoulos G . Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 2000; 286(5449):2511-4. DOI: 10.1126/science.286.5449.2511. View

Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1(1):27-31. DOI: 10.1038/nm0195-27. View

Davis S, Aldrich T, Jones P, Acheson A, Compton D, Jain V . Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 1996; 87(7):1161-9. DOI: 10.1016/s0092-8674(00)81812-7. View

Suri C, Jones P, Patan S, Bartunkova S, Maisonpierre P, Davis S . Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996; 87(7):1171-80. DOI: 10.1016/s0092-8674(00)81813-9. View

Schlaeger T, Bartunkova S, Lawitts J, TEICHMANN G, Risau W, Deutsch U . Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A. 1997; 94(7):3058-63. PMC: 20321. DOI: 10.1073/pnas.94.7.3058. View

Shalaby F, Ho J, Stanford W, Fischer K, Schuh A, Schwartz L . A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 1997; 89(6):981-90. DOI: 10.1016/s0092-8674(00)80283-4. View

Maisonpierre P, Suri C, Jones P, Bartunkova S, Wiegand S, Radziejewski C . Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997; 277(5322):55-60. DOI: 10.1126/science.277.5322.55. View

Wang H, Chen Z, Anderson D . Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 1998; 93(5):741-53. DOI: 10.1016/s0092-8674(00)81436-1. View

10.

Suri C, McClain J, Thurston G, McDonald D, Zhou H, Oldmixon E . Increased vascularization in mice overexpressing angiopoietin-1. Science. 1998; 282(5388):468-71. DOI: 10.1126/science.282.5388.468. View

11.

Stratmann A, Risau W, Plate K . Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol. 1998; 153(5):1459-66. PMC: 1853417. DOI: 10.1016/S0002-9440(10)65733-1. View

12.

Holash J, Maisonpierre P, Compton D, Boland P, Alexander C, Zagzag D . Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 1999; 284(5422):1994-8. DOI: 10.1126/science.284.5422.1994. View

13.

Holash J, Wiegand S, Yancopoulos G . New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene. 1999; 18(38):5356-62. DOI: 10.1038/sj.onc.1203035. View

14.

Gerety S, Wang H, Chen Z, Anderson D . Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell. 1999; 4(3):403-14. DOI: 10.1016/s1097-2765(00)80342-1. View

15.

Thurston G, Rudge J, Ioffe E, Zhou H, Ross L, Croll S . Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000; 6(4):460-3. DOI: 10.1038/74725. View

16.

Yancopoulos G, Davis S, Gale N, Rudge J, Wiegand S, Holash J . Vascular-specific growth factors and blood vessel formation. Nature. 2000; 407(6801):242-8. DOI: 10.1038/35025215. View

17.

Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G . Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol. 2001; 230(2):139-50. DOI: 10.1006/dbio.2000.9957. View

18.

Gale N, Baluk P, Pan L, Kwan M, Holash J, DeChiara T . Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol. 2001; 230(2):151-60. DOI: 10.1006/dbio.2000.0112. View

19.

Isner J . Myocardial gene therapy. Nature. 2002; 415(6868):234-9. DOI: 10.1038/415234a. View

20.

Subramaniam A, Jones W, Gulick J, Wert S, Neumann J, Robbins J . Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 1991; 266(36):24613-20. View